Conversion surgery for locally advanced malignant pleural mesothelioma

被引：0

作者：

Terada, Yukihiro ^{[1
]}

Isaka, Mitsuhiro ^{[1
]}

Murakami, Haruyasu ^{[2
]}

Kawata, Takuya ^{[3
]}

Konno, Hayato ^{[1
]}

Kojima, Hideaki ^{[1
]}

Mizuno, Tetsuya ^{[1
]}

Ohde, Yasuhisa ^{[1
]}

机构：

[1] Shizuoka Canc Ctr, Div Thorac Surg, Shimonagakubo 1007, Nagaizumi, Shizuoka 4118777, Japan

[2] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan

[3] Shizuoka Canc Ctr, Div Pathol, Shizuoka, Japan

来源：

GENERAL THORACIC AND CARDIOVASCULAR SURGERY | 2020年 / 68卷 / 12期

关键词：

Malignant pleural mesothelioma; Conversion surgery; Locally advanced; Pleurectomy; decortication; Chemotherapy; PLEURECTOMY; MULTICENTER; SURVIVAL;

D O I：

10.1007/s11748-020-01329-y

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Two women in their sixties were diagnosed with inoperable locally advanced epithelioid malignant pleural mesothelioma, c-stage IIIB. Post-chemotherapy, the tumors down-staged to yc-stage IA, and pleurectomy/decortication were performed. The pathological diagnoses were p-stages II and IA. One patient had tumor recurrence 6 months after surgery; she is currently undergoing fourth-line chemotherapy and is alive 30 months postoperatively. The second patient had tumor recurrence 4 months after surgery and died 2 months later. Conversion surgery for advanced malignant mesothelioma does not improve progression-free survival but might have a chance to extend overall survival in selected patients without deteriorating performance status.

引用

页码：1547 / 1550

页数：4

共 8 条

[1] Prospective Study on Functional Results After Lung-Sparing Radical Pleurectomy in the Management of Malignant Pleural Mesothelioma [J].

Boeluekbas, Servet ;

Eberlein, Michael ;

Schirren, Joachim .

JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (05) :900-905

[2] A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma [J].

Cao, Christopher ;

Tian, David ;

Park, John ;

Allan, James ;

Pataky, Kristopher A. ;

Yan, Tristan D. .

LUNG CANCER, 2014, 83 (02) :240-245

[3] NCCN Guidelines® Insights Malignant Pleural Mesothelioma, Version 3.2016 Featured Updates to the NCCN Guidelines [J].

Ettinger, David S. ;

Wood, Douglas E. ;

Akerley, Wallace ;

Bazhenova, Lyudmila A. ;

Borghaei, Hossein ;

Camidge, David Ross ;

Cheney, Richard T. ;

Chirieac, Lucian R. ;

D'Amico, Thomas A. ;

Dilling, Thomas ;

Dobelbower, Michael ;

Govindan, Ramaswamy ;

Hennon, Mark ;

Horn, Leora ;

Jahan, Thierry M. ;

Komaki, Ritsuko ;

Lackner, Rudy P. ;

Lanuti, Michael ;

Lilenbaum, Rogerio ;

Lin, Jules ;

Loo, Billy W., Jr. ;

Martins, Renato ;

Otterson, Gregory A. ;

Patel, Jyoti D. ;

Pisters, Katherine M. ;

Reckamp, Karen ;

Riely, Gregory J. ;

Schild, Steven E. ;

Shapiro, Theresa A. ;

Sharma, Neelesh ;

Swanson, Scott J. ;

Stevenson, James ;

Tauer, Kurt ;

Yang, Stephen C. ;

Gregory, Kristina ;

Hughes, Miranda .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (07) :825-836

[4] Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years [J].

Friedberg, Joseph S. ;

Simone, Charles B., II ;

Culligan, Melissa J. ;

Barsky, Andrew R. ;

Doucette, Abigail ;

McNulty, Sally ;

Hahn, Stephen M. ;

Alley, Evan ;

Sterman, Daniel H. ;

Glatstein, Eli ;

Cengel, Keith A. .

ANNALS OF THORACIC SURGERY, 2017, 103 (03) :912-919

[5] A Phase II Study of Nivolumab: A Multicenter, Open-Label, Single Arm Study in Malignant Pleural Mesothelioma (MERIT) [J].

Goto, Y. ;

Okada, M. ;

Kijima, T. ;

Aoe, K. ;

Kato, T. ;

Fujimoto, N. ;

Nakagawa, K. ;

Takeda, Y. ;

Hida, T. ;

Kanai, K. ;

Imamura, F. ;

Oizumi, S. ;

Takahashi, T. ;

Takenoyama, M. ;

Tanaka, H. ;

Ohe, Y. .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S1883-S1883

[6] Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma [J].

Nakas, Apostolos ;

von Meyenfeldt, Eric ;

Lau, Kelvin ;

Muller, Salli ;

Waller, David .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2012, 41 (05) :1031-1036

[7] Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma [J].

Vogelzang, NJ ;

Rusthoven, JJ ;

Symanowski, J ;

Denham, C ;

Kaukel, E ;

Ruffie, P ;

Gatzemeier, U ;

Boyer, M ;

Emri, S ;

Manegold, C ;

Niyikiza, C ;

Paoletti, P .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2636-2644

[8] Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter survey [J].

Zucali, P. A. ;

Simonelli, M. ;

Michetti, G. ;

Tiseo, M. ;

Ceresoli, G. L. ;

Collova, E. ;

Follador, A. ;

Lo Dico, M. ;

Moretti, A. ;

De Vincenzo, F. ;

Lorenzi, E. ;

Perrino, M. ;

Giordano, L. ;

Farina, G. ;

Santoro, A. ;

Garassino, M. .

LUNG CANCER, 2012, 75 (03) :360-367

← 1 →